Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...
Innova Engineered Plastics acquires SSK assets in Mexicali adding five injection molding machines and 10,000 sq ft production ...
The integration of flexible manufacturing, process intensification, and sustainability is redefining the global supply chain.
The new facility accelerates catheter design with rapid prototyping, testing capabilities, and university research ...
We are witnessing a transition from passive automation to integrated, agentic autonomy — a shift that moves beyond simple ...
Tech Xplore on MSN
Why 5G alone may not be enough for tomorrow's factories
As manufacturers race toward smarter, faster and more automated production, the networks holding those systems together are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback